Reasons Viking Therapeutics Stock Could 10X If Obesity
Investors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...
Compare ongoing fees across top dividend ETFs for 2024 to find the funds with the lowest drag on your returns and best value.
28,084 articlesInvestors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...
As mortgage workflows accelerate, industry insiders argue the real hurdle is trust, not velocity. This report examine...
Markets have celebrated a long rally, but chair nominee kevin warsh's real test may lie in credibility, independence,...
Imagine a tech titan quietly owning a defense tech unicorn valued at $1B. This piece breaks down the implications for...
Hajime Construction enlarges its U.S. footprint by acquiring a 51% stake in Wright Homes of Utah, gaining management ...
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
A late-stage private AI company is inviting retail buyers to participate in a sub-$1 pre-IPO round, with shares at $0...
A viral parody drawing 110 million views isn’t just a pop culture moment—it also tests money decisions. This guide sh...
AI-driven payroll reductions accelerate as major firms trim jobs, altering earnings and market sentiment in May 2026.
Doximity is due to report Q4 results after the close, with analysts keyed to FY2027 guidance and margin trajectory as...
Bitcoin and the broader crypto market face renewed volatility as four pivotal drivers emerge this week, including cor...
Divisadero Street Capital Management upped its stake in Dave (DAVE), fueling questions about a potential buying oppor...